フルテキストURL fulltext.pdf
著者 Iwamuro, Masaya| Takahashi, Takahide| Tanaka, Takehiro| Toji, Tomohiro| Hiraoka, Sakiko| Kawano, Seiji| Kawahara, Yoshiro| Okada, Hiroyuki|
発行日 2020-10-07
出版物タイトル Case Reports in Gastrointestinal Medicine
2020巻
出版者 Hindawi
開始ページ 8893604
ISSN 2090-6528
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2020 Masaya Iwamuro et al.
論文のバージョン publisher
PubMed ID 33083067
DOI 10.1155/2020/8893604
Web of Science KeyUT 000583201400001
関連URL isVersionOf https://doi.org/10.1155/2020/8893604
フルテキストURL fulltext.pdf Figure.tif
著者 Tomoda, Takeshi| Kato, Hironari| Miyamoto, Kazuya| Matsumi, Akihiro| Ueta, Eijiro| Fujii, Yuuki| Saragai, Yousuke| Yamazaki, Tatsuhiro| Uchida, Daisuke| Matsumoto, Kazuyuki| Horiguchi, Shigeru| Tsutsumi, Koichiro| Okada, Hiroyuki|
キーワード diclofenac low dose post‐ERCP pancreatitis
備考 This is the peer reviewed version of the following article: Takeshi Tomoda et. al. Efficacy of low dose rectal diclofenac for preventing post‐endoscopic retrograde cholangiopancreatography pancreatitis: Propensity score‐matched analysis. Digestive Endoscopy, which has been published in final form at https://doi.org/10.1111/den.13828. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.|
発行日 2020-09-02
出版物タイトル Digestive Endoscopy
33巻
出版者 Wiley
開始ページ 656
終了ページ 662
ISSN 0915-5635
NCID AA10907137
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン author
PubMed ID 32881078
DOI 10.1111/den.13828
Web of Science KeyUT 000577757600001
関連URL isVersionOf https://doi.org/10.1111/den.13828
フルテキストURL fulltext.pdf
著者 Miyamoto, Kazuya| Matsumoto, Kazuyuki| Kato, Hironari| Yoshida, Ryuichi| Umeda, Yuzo| Inoue, Hirohumi| Tanaka, Takehiro| Matsumi, Akihiro| Saragai, Yosuke| Fujii, Yuki| Yamazaki, Tatsuhiro| Uchida, Daisuke| Tomoda, Takeshi| Horiguchi, Shigeru| Yagi, Takahito| Okada, Hiroyuki|
キーワード IPMN PJC LBC BD SurePath
発行日 2020-09-29
出版物タイトル BMC Gastroenterology
20巻
1号
出版者 BMC
開始ページ 319
ISSN 1471-230X
NCID AA12034934
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © The Author(s). 2020
論文のバージョン publisher
PubMed ID 32993498
DOI 10.1186/s12876-020-01465-y
Web of Science KeyUT 000576989100004
関連URL isVersionOf https://doi.org/10.1186/s12876-020-01465-y
フルテキストURL fulltext.pdf
著者 Matsumoto, Kazuyuki| Kato, Hironari| Horiguchi, Shigeru| Tomoda, Takeshi| Matsumi, Akihiro| Ishihara, Yuki| Saragai, Yosuke| Takada, Saimon| Muro, Shinichiro| Uchida, Daisuke| Okada, Hiroyuki|
キーワード Endoscopic ultrasound-guided fine needle aspiration Pancreaticobiliary cancer Neoplasm recurrence
発行日 2020
出版物タイトル Gut and Liver
14巻
5号
出版者 Gut and Liver
開始ページ 652
終了ページ 658
ISSN 1976-2283
NCID AA12329814
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン publisher
PubMed ID 31818050
NAID 120006891207
DOI 10.5009/gnl19200
Web of Science KeyUT 000569359000016
関連URL isVersionOf https://doi.org/10.5009/gnl19200
フルテキストURL fulltext.pdf
著者 Hirai, Mami| Kinugasa, Hideaki| Nouso, Kazuhiro| Yamamoto, Shumpei| Terasawa, Hiroyuki| Onishi, Yuma| Oyama, Atsushi| Adachi, Takuya| Wada, Nozomu| Sakata, Masahiro| Yasunaka, Tetsuya| Onishi, Hideki| Shiraha, Hidenori| Takaki, Akinobu| Okada, Hiroyuki|
キーワード ctDNA hepatocellular carcinoma liquid biopsy prediction prognosis TERT promoter mutation
発行日 2020-08-24
出版物タイトル Journal of Gastroenterology and Hepatology
36巻
出版者 Wiley
開始ページ 1118
終了ページ 1125
ISSN 0815-9319
NCID AA10727383
資料タイプ 学術雑誌論文
論文のバージョン author
PubMed ID 32830343
DOI 10.1111/jgh.15227
Web of Science KeyUT 000568136400001
関連URL isVersionOf https://doi.org/10.1111/jgh.15227
フルテキストURL fulltext.pdf Figure_A.tif Figure_B.tif Figure_C.tif Figure_D.tif
著者 Ako, Soichiro| Kawano, Seiji| Okada, Hiroyuki|
発行日 2020-07-23
出版物タイトル Clinical Gastroenterology and Hepatology
20巻
2号
出版者 AGA Institute
開始ページ e12
終了ページ e13
ISSN 15423565
NCID AA11845942
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2020 by the AGA Institute
論文のバージョン author
PubMed ID 32712389
DOI 10.1016/j.cgh.2020.07.044
関連URL isVersionOf https://doi.org/10.1016/j.cgh.2020.07.044
JaLCDOI 10.18926/AMO/60364
フルテキストURL 74_4_275.pdf
著者 Muro, Taiko| Nakamura, Shinichiro| Takaki, Akinobu| Onishi, Hideki| Wada, Nozomu| Yasunaka, Tetsuya| Uchida, Daisuke| Oyama, Atsushi| Adachi, Takuya| Shiraha, Hidenori| Okada, Hiroyuki|
抄録 Radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is a promising method for controlling tumors, although it does not entirely eliminate recurrence. Oxidative stress is associated with the progression of hepatocarcinogenesis, while also acting as an anticancer response. The objective of the present study was to investigate the factors influencing post-RFA outcomes. We recruited 235 newly diagnosed HCC patients who received RFA for single tumors. The patients with recurrence were sub-grouped into early and segmental recurrence groups. The characteristics of the sub-grouped patients were evaluated, including by measuring oxidative stress marker reactive oxygen metabolites and antioxidant marker OXY-adsorbent tests. The factors associated with poor survival were a high Child-Pugh score and early recurrence within 2 years in the same segment. The patients who experienced recurrence within 2 years in the same segment showed a larger tumor diameter than did others. According to a multivariate analysis, the OXY values were also significantly low in these patients. In conclusion, maintaining the antioxidant reservoir function with a high OXY value might be necessary to prevent early recurrence within the RFA-treated segment.
キーワード oxidative stress hepatocellular carcinoma recurrence, radiofrequency ablation
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2020-08
74巻
4号
出版者 Okayama University Medical School
開始ページ 275
終了ページ 283
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 32843758
Web of Science KeyUT 000562508700002
NAID 120006880203
JaLCDOI 10.18926/AMO/60363
フルテキストURL 74_4_265.pdf
著者 Inokuchi, Toshihiro| Hiraoka, Sakiko| Yasutomi, Eriko| Oka, Shohei| Yamasaki, Yasushi| Kinugasa, Hideaki| Takahar, Masahiro| Kawano, Seiji| Harada, Keita| Okada, Hiroyuki| Kato, Jun|
抄録 Determining factors that predict a favorable disease course without anti-tumor necrosis factor (TNF) agents would help establish a more cost-effective strategy for Crohn’s disease (CD). A retrospective chart review was performed for CD patients with disease durations > 10 years who had not received anti-TNF agents as first-line therapy. Patients were divided into 2 groups: those who received neither anti-TNF agents nor bowel resection (G1), and those who had received an anti-TNF agent and/or bowel resection (G2). The patient backgrounds, therapies and clinical courses were compared between the groups. A total of 62 CD patients met the inclusion criteria (males: 71%; median duration of follow-up: 19 years). Six patients were included in G1; they were significantly less likely to have upper gastrointestinal lesions than G2 (p=0.007). A multivariate analysis revealed that the significant factors for avoidance of bowel resection without anti-TNF treatment were non-stricturing and non-penetrating behaviors, and absence of upper gastrointestinal lesions at the diagnosis (hazard ratios 0.41 and 0.52; p=0.004 and 0.04, respectively). In consideration of the long treatment course of CD, patients with non-stricturing and non-penetrating behaviors and no upper gastrointestinal lesions should not be treated with anti-TNF agents as first-line therapy.
キーワード Crohn’s disease anti-TNF agent upper gastrointestinal lesion bamboo joint-like appearance
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2020-08
74巻
4号
出版者 Okayama University Medical School
開始ページ 265
終了ページ 274
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 32843757
Web of Science KeyUT 000562508700001
NAID 120006880202
フルテキストURL fulltext.pdf
著者 Uchida, Daisuke| Takaki, Akinobu| Oyama, Atsushi| Adachi, Takuya| Wada, Nozomu| Onishi, Hideki| Okada, Hiroyuki|
キーワード oxidative stress chronic hepatitis hepatocellular carcinoma
発行日 2020-05-28
出版物タイトル Nutrients
12巻
6号
出版者 MDPI
開始ページ 1576
ISSN 2072-6643
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2020 by the authors.
論文のバージョン publisher
PubMed ID 32481552
DOI 10.3390/nu12061576
Web of Science KeyUT 000554005200001
関連URL isVersionOf https://doi.org/10.3390/nu12061576
フルテキストURL fulltext.pdf
著者 Tanabe, Katsuyuki| Kanzaki, Hiromitsu| Wada, Takahira| Nakashima, Yuri| Sugiyama, Hitoshi| Okada, Hiroyuki| Wada, Jun|
キーワード case report gastric cancer IgA nephropathy nivolumab steroid
発行日 2020-05-22
出版物タイトル Medicine
99巻
21号
出版者 Lippincott, Williams & Wilkins
開始ページ e20464
ISSN 0025-7974
NCID AA00728867
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2020 the Author(s).
論文のバージョン publisher
PubMed ID 32481351
DOI 10.1097/MD.0000000000020464
Web of Science KeyUT 000551508200106
関連URL isVersionOf https://doi.org/10.1097/MD.0000000000020464
フルテキストURL fulltext.pdf
著者 Yamamoto, Shumpei| Onishi, Hideki| Takaki, Akinobu| Oyama, Atsushi| Adachi, Takuya| Wada, Nozomu| Sakata, Masahiro| Yasunaka, Tetsuya| Shiraha, Hidenori| Okada, Hiroyuki|
キーワード Hepatocellular carcinoma Hepatic arterial infusion chemotherapy Low-dose cisplatin plus 5-fluorouracil alpha-Fetoprotein Des-gamma-carboxy prothrombin
発行日 2020-04-21
出版物タイトル Gastrointestinal Tumors
7巻
3号
出版者 Karger
開始ページ 83
終了ページ 92
ISSN 2296-3774
NCID AA12665877
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2020 The Author(s)
論文のバージョン publisher
DOI 10.1159/000506941
Web of Science KeyUT 000551254300003
関連URL isVersionOf https://doi.org/10.1159/000506941
フルテキストURL fulltext.pdf
著者 Iwamuro, Masaya| Murakami, Toshi| Tanaka, Takehiro| Oka, Shohei| Kawano, Seiji| Kawahara, Yoshiro| Okada, Hiroyuki|
発行日 2020-06-04
出版物タイトル Case Reports in Gastrointestinal Medicine
2020巻
出版者 Hindawi
開始ページ 6381670
ISSN 2090-6528
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2020 Masaya Iwamuro et al.
論文のバージョン publisher
PubMed ID 32566328
DOI 10.1155/2020/6381670
Web of Science KeyUT 000542326600001
関連URL isVersionOf https://doi.org/10.1155/2020/6381670
フルテキストURL fulltext.pdf
著者 Iwamuro, Masaya| Miyahara, Koji| Sakaguchi, Chihiro| Takenaka, Ryuta| Kobayashi, Sayo| Mouri, Hirokazu| Tanaka, Shigetomi| Toyokawa, Tatsuya| Tanaka, Shouichi| Nishimura, Mamoru| Yamauchi, Kenji| Tanaka, Takehiro| Okada, Hiroyuki|
キーワード 18F-fluorodeoxyglucose-positron emission tomography mesenchymal tumor gastric neoplasms gastrointestinal stromal tumor schwannoma
発行日 2020-05-01
出版物タイトル Journal of Clinical Medicine
9巻
5号
出版者 MDPI
開始ページ 1301
ISSN 2077-0383
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2020 by the authors.
論文のバージョン publisher
PubMed ID 32370028
DOI 10.3390/jcm9051301
Web of Science KeyUT 000540223800058
関連URL isVersionOf https://doi.org/10.3390/jcm9051301
JaLCDOI 10.18926/AMO/59958
フルテキストURL 74_3_245.pdf
著者 Yamamoto, Shumpei| Takayama, Hiroshi| Shimodate, Yuichi| Takezawa, Rio| Nishimura, Naoyuki| Doi, Akira| Mouri, Hirokazu| Matsueda, Kazuhiro| Mizuno, Motowo| Okada, Hiroyuki|
抄録 Antithrombotic therapy is a major risk factor for delayed bleeding after endoscopic submucosal dissection (ESD) for gastric neoplasia. A potassium-competitive acid blocker, vonoprazan, is expected to prevent delayed bleeding better than conventional proton pomp inhibitors (PPIs), but the evidence is controversial. We sought to clarify the efficacy of vonoprazan for prevention of delayed bleeding after gastric ESD in patients under antithrombotic therapy. We prospectively registered 50 patients who underwent gastric ESD while receiving antithrombotic therapy and vonoprazan in our institution between October 2017 and September 2018. The incidence of delayed bleeding was compared with that in a historical control group of 116 patients treated with conventional PPI. We also evaluated risk factors associated with delayed bleeding. Delayed bleeding was observed in 8 of 50 patients (16.0%), which was not dissimilar from the incidence in the historical control group (12.1%) (p=0.49). In the univariate analysis, age (> 70 years) (p=0.034), multiple antithrombotic drug use (p<0.01), procedure time (> 200 min) (p=0.038) and tumor size (> 40 mm) (p<0.01) were associated with delayed bleeding after gastric ESD, but vonoprazan was not (p=0.49). Vonoprazan may not be more effective than conventional PPIs in preventing delayed bleeding after gastric ESD in patients receiving antithrombotic therapy.
キーワード vonoprazan endoscopic submucosal dissection antithrombotic drug gastric cancer
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2020-06
74巻
3号
出版者 Okayama University Medical School
開始ページ 245
終了ページ 250
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 32577023
Web of Science KeyUT 000543363400008
NAID 120006862799
JaLCDOI 10.18926/AMO/59957
フルテキストURL 74_3_237.pdf
著者 Oyama, Atsushi| Uchida, Daisuke| Shiraha, Hidenori| Sawahara, Hiroaki| Kato, Ryo| Iwamuro, Masaya| Horiguchi, Shigeru| Okada, Hiroyuki|
抄録 The physiological role of the reduced expression of immortalized cells (REIC)/Dickkopf-3 (Dkk-3) protein in patients with hepatocellular carcinoma (HCC) remains unclear. In this study, we evaluated the effect of the REIC/Dkk-3 protein on HCC cell proliferation and assessed the relationship between the serum REIC/Dkk-3 protein level and the prognosis in patients with HCC. We evaluated the REIC/Dkk-3 protein-induced anticancer effects on Huh7 and Hep3B cells (HCC cell lines) in the presence of peripheral blood mononuclear cells (PBMCs), and found that combination treatment with REIC/Dkk-3 protein and PBMCs reduced the proliferation of HCC cells (Hep3B: 82.0%±16.3%; Huh7: 72.6%±9.1%). We also studied 194 HCC patients who underwent primary liver resection or primary radiofrequency ablation from 2008 to 2017. Serum REIC/Dkk-3 protein levels were measured by an enzyme-linked immunosorbent assay and compared to the prognostic data. The 3-year disease-free survival of the REIC/Dkk-3 high group was significantly higher than that in the REIC/Dkk-3 low group. In conclusion, this is the first study investigating the relationship between HCC patient survival and serum REIC/Dkk-3 protein levels in a large population. Based on the results, the serum REIC/Dkk-3 protein level should be considered a new prognostic marker for patients with HCC.
キーワード enzyme-linked immunosorbent assay liver resection primary radiofrequency ablation Huh7 Hep3B
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2020-06
74巻
3号
出版者 Okayama University Medical School
開始ページ 237
終了ページ 243
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2020 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 32577022
Web of Science KeyUT 000543363400007
NAID 120006862798
フルテキストURL fulltext.pdf
著者 Iwamuro, Masaya| Takahashi, Takahide| Ota, Yoko| Tanaka, Takehiro| Asada, Noboru| Yano, Shuya| Uka, Mayu| Nakamura, Rei| Baba, Yuki| Kawano, Seiji| Kawahara, Yoshiro| Okada, Hiroyuki|
発行日 2020-04-09
出版物タイトル Case Reports in Gastrointestinal Medicine
2020巻
出版者 Hindawi
開始ページ 7947540
ISSN 2090-6528
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2020 Masaya Iwamuro et al.
論文のバージョン publisher
PubMed ID 32328319
DOI 10.1155/2020/7947540
Web of Science KeyUT 000528921300002
関連URL isVersionOf https://doi.org/10.1155/2020/7947540
フルテキストURL text_correction.pdf table3_correction.pdf
著者 Tomoda, Takeshi | Kato, Hironari| Miyamoto, Kazuya| Matsumi, Akihiro| Ueta, Eijiro| Fujii, Yuuki| Saragai, Yousuke| Yamazaki, Tatsuhiro| Uchida, Daisuke| Matsumoto, Kazuyuki| Horiguchi, Shigeru| Tsutsumi, Koichiro| Okada, Hiroyuki|
備考 Correction to: Surgical Endoscopy https://doi.org/10.1007/s00464-020-07385-y|
発行日 2020-02-06
出版物タイトル Surgical Endoscopy
35巻
1号
出版者 Springer
開始ページ 239
終了ページ 240
ISSN 09302794
NCID AA10750363
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン author
PubMed ID 32030547
DOI 10.1007/s00464-020-07399-6
Web of Science KeyUT 000515963500002
関連URL isVersionOf https://doi.org/10.1007/s00464-020-07399-6
フルテキストURL fulltext.pdf table.pdf
著者 Tomoda, Takeshi| Kato, Hironari| Miyamoto, Kazuya| Matsumi, Akihiro| Ueta, Eijiro| Fujii, Yuuki| Saragai, Yousuke| Yamazaki, Tatsuhiro| chida, Daisuke| atsumoto, Kazuyuki| Horiguchi, Shigeru| Tsutsumi, Koichiro| Okada, Hiroyuki|
キーワード Malignant biliary obstruction Double-balloon enteroscope Endoscopic retrograde cholangiopancreatography Surgically altered anatomy
備考 This fulltext is aailable in Jan. 2021.|
発行日 2020-01-16
出版物タイトル Surgical Endoscopy
ISSN 09302794
NCID AA10750363
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン author
PubMed ID 31950273
DOI 10.1007/s00464-020-07385-y
Web of Science KeyUT 000507705600001
関連URL isVersionOf https://doi.org/10.1007/s00464-020-07385-y
タイトル(別表記) Efficacy of Helicobacter pylori eradication followed by the administration of a proton pump inhibitor (PPI) or PPI plus a prokinetic in H. pylori-positive patients with dyspepsia
フルテキストURL 131_139.pdf
著者 三浦 公| 岩室 雅也| 豊川 達也| 竹中 龍太| 井上 雅文| 伊藤 守| 岡田 裕之|
抄録 To investigate whether treatment comprised of Helicobacter pylori eradication followed by the administration of a proton pump inhibitor (PPI) alone and a dual treatment with a PPI plus a prokinetic agent helps relieve symptoms, we treated 26 patients with H. pylori infection and dyspepsia with the sequential treatment and assessed their symptoms. Scores for gastroesophageal reflux disease (GERD) and dyspepsia in a modified F-scale were significantly improved after the eradication of H. pylori, and symptoms were completely relieved in 13 patients. The remaining 13 patients received 4-week treatment with the PPI rabeprazole, and their GERD scores significantly improved after the treatment. The symptoms of five patients completely disappeared ; the other eight patients required dual treatment with a PPI plus the prokinetic acotiamide. Early satiety tended to be relieved after the dual treatment, but the improvement was not significant. Thus, in patients with dyspepsia and an H. pylori infection, the H. pylori should be eradicated first. The administration of a PPI is useful in patients with GERD symptoms, and a PPI+ acotiamide may be beneficial for residual symptoms of early satiety.
キーワード 機能性ディスペプシア (functional dyspepsia) ヘリコバクター・ピロリ (Helicobacter pylori) プロトンポンプ阻害剤 (proton pomp inhibitor) 消化管運動機能改善剤 (acotiamide)
出版物タイトル 岡山医学会雑誌
発行日 2019-12-02
131巻
3号
開始ページ 139
終了ページ 143
ISSN 0030-1558
関連URL isVersionOf https://doi.org/10.4044/joma.131.139
言語 日本語
著作権者 Copyright (c) 2019 岡山医学会
論文のバージョン publisher
DOI 10.4044/joma.131.139
NAID 130007782646
フルテキストURL fulltext.pdf
著者 Uchida, Daisuke| Kato, Hironari| Matsumoto, Kazuyuki| Ishihara, Yuki| Matsumi, Akihiro| Saragai, Yosuke| Takada, Saimon| Yabe, Shuntaro| Muro, Shinichiro| Tomoda, Takeshi| Horiguchi, Shigeru| Okada, Hiroyuki|
キーワード Endoscopic ultrasound Diagnostic screening program Pancreatic diseases Biliary tract diseases
発行日 2019-12-18
出版物タイトル BMC Gastroenterology
19巻
1号
出版者 BMC
開始ページ 220
ISSN 1471-230X
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © The Author(s). 2019
論文のバージョン publisher
PubMed ID 31852458
DOI 10.1186/s12876-019-1141-7
Web of Science KeyUT 000510482800002
関連URL isVersionOf https://doi.org/10.1186/s12876-019-1141-7